NCT03312049

Brief Summary

The study focuses on the causal relationship between mycotoxin exposure (particularly aflatoxin B1), birth outcomes, and height for age among young children in Nepal. Previous studies have shown a strong association of stunting with mycotoxin exposure yet causality has not been proven. Thus, this study will provide a better understanding of the association between maternal and/or early life mycotoxin exposure (rates in the blood and breast milk) and infant and young child growth. This information is essential if we are to more fully understand and effectively address the high rates of stunting in Asia.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,675

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2015

Typical duration for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 6, 2015

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

September 11, 2017

Completed
1 month until next milestone

First Posted

Study publicly available on registry

October 17, 2017

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2019

Completed
Last Updated

May 10, 2019

Status Verified

May 1, 2019

Enrollment Period

3.7 years

First QC Date

September 11, 2017

Last Update Submit

May 8, 2019

Conditions

Keywords

Aflatoxin B1Aflatoxin M1AflatoxinMycotoxinStuntingLinear growthPregnancyBirth outcomesNepal

Outcome Measures

Primary Outcomes (1)

  • Change in Height for Age Z-scores (HAZ)

    Height for Age Z-scores based on the World Health Organization's 2006 Child Growth Standards, HAZ \< -6 and \> 6

    Measured at birth and when infant turns 3, 6, 9, 12, 18 and 24 months of age

Secondary Outcomes (6)

  • Aflatoxin M1 (breast milk)

    Measured when infant is 3 months of age

  • Low birth weight

    Measured at birth

  • Aflatoxin B1 (serum)

    Measured during pregnancy

  • Change in infant aflatoxin B1

    Measured when infant turns 3, 6, 12 and 18 months of age

  • Fumonisin B, Deoxynivalenol (DON) (urine)

    Measured when infant turns 18 months of age

  • +1 more secondary outcomes

Eligibility Criteria

Age16 Years - 49 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsPregnant women and adolescent girls
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

All pregnant women and adolescent girls aged 16-49 years and living in the study areas will be invited to join the study. Women who are less than 30 weeks into their gestation will be eligible to participate if their expected delivery date falls within the enrollment period.

You may qualify if:

  • Pregnant women and adolescent girls (less than 30 weeks gestation)
  • Aged 16-49 years
  • Living in the study area
  • Intends to reside in the study area through the study period
  • Intends to deliver in the study area
  • Provides informed consent herself or through a legal guardian
  • Live Birth
  • Single Birth

You may not qualify if:

  • Severely malnourished mother \<17.5 cm
  • Severely anemic mother hemoglobin\<7 g/dL
  • Pregnancy induced hypertension
  • Congenital anomalies
  • Very low birth weight \<1500 g
  • Sepsis
  • Respiratory distress syndrome
  • Severe malnutrition infant ≤-3 WFH z-score (3 months), \<11.5 cm MUAC or edema
  • Severe anemia infant (hemoglobin\<7 g/dL)
  • Fetal loss
  • Early termination of pregnancy
  • Still births
  • Infant death
  • Relocation of household

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Lamichhane A, Webb P, Andrews-Trevino J, Pokharel A, Acharya S, Shrestha R, Davis D, Baral K, Wang JS, Xue K, Paudel K, Ghosh S. Dietary determinants of aflatoxin B1-lysine adduct among infants in Nepal. Eur J Clin Nutr. 2022 Nov;76(11):1557-1565. doi: 10.1038/s41430-022-01142-1. Epub 2022 Apr 20.

  • Andrews-Trevino JY, Webb P, Shively G, Kablan A, Baral K, Davis D, Paudel K, Shrestha R, Pokharel A, Acharya S, Wang JS, Xue KS, Ghosh S. Aflatoxin exposure and child nutrition: measuring anthropometric and long-bone growth over time in Nepal. Am J Clin Nutr. 2021 Apr 6;113(4):874-883. doi: 10.1093/ajcn/nqaa397.

  • Andrews-Trevino JY, Webb P, Shively G, Rogers BL, Baral K, Davis D, Paudel K, Pokharel A, Shrestha R, Wang JS, Ghosh S. Relatively Low Maternal Aflatoxin Exposure Is Associated with Small-for-Gestational-Age but Not with Other Birth Outcomes in a Prospective Birth Cohort Study of Nepalese Infants. J Nutr. 2019 Oct 1;149(10):1818-1825. doi: 10.1093/jn/nxz122.

Biospecimen

Retention: SAMPLES WITH DNA

Serum aflatoxin B1-lysine adduct levels Breast milk aflatoxin M1 levels

MeSH Terms

Conditions

Growth DisordersBirth WeightFailure to Thrive

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsBody WeightSigns and Symptoms

Study Officials

  • Patrick Webb, PhD

    Tufts University

    PRINCIPAL INVESTIGATOR
  • Kedar P Baral, MD

    Patan Academy of Health Sciences

    PRINCIPAL INVESTIGATOR
  • Shibani Ghosh, PhD

    Tufts University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Alexander McFarlane Professor of Nutrition

Study Record Dates

First Submitted

September 11, 2017

First Posted

October 17, 2017

Study Start

July 6, 2015

Primary Completion

March 31, 2019

Study Completion

March 31, 2019

Last Updated

May 10, 2019

Record last verified: 2019-05

Data Sharing

IPD Sharing
Will not share